JPH11512400A5 - - Google Patents

Info

Publication number
JPH11512400A5
JPH11512400A5 JP1997511499A JP51149997A JPH11512400A5 JP H11512400 A5 JPH11512400 A5 JP H11512400A5 JP 1997511499 A JP1997511499 A JP 1997511499A JP 51149997 A JP51149997 A JP 51149997A JP H11512400 A5 JPH11512400 A5 JP H11512400A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP1997511499A
Other languages
English (en)
Japanese (ja)
Other versions
JPH11512400A (ja
JP4101876B2 (ja
Filing date
Publication date
Priority claimed from AUPN5311A external-priority patent/AUPN531195A0/en
Application filed filed Critical
Publication of JPH11512400A publication Critical patent/JPH11512400A/ja
Publication of JPH11512400A5 publication Critical patent/JPH11512400A5/ja
Application granted granted Critical
Publication of JP4101876B2 publication Critical patent/JP4101876B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP51149997A 1995-09-11 1996-09-10 抗炎症活性を有する脂質抽出物 Expired - Lifetime JP4101876B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU5311 1983-08-10
AUPN5311A AUPN531195A0 (en) 1995-09-11 1995-09-11 Lipid extract having anti-inflamatory activity
PCT/AU1996/000564 WO1997009992A1 (en) 1995-09-11 1996-09-10 Lipid extract having anti-inflammatory activity

Publications (3)

Publication Number Publication Date
JPH11512400A JPH11512400A (ja) 1999-10-26
JPH11512400A5 true JPH11512400A5 (enExample) 2004-09-16
JP4101876B2 JP4101876B2 (ja) 2008-06-18

Family

ID=3789640

Family Applications (1)

Application Number Title Priority Date Filing Date
JP51149997A Expired - Lifetime JP4101876B2 (ja) 1995-09-11 1996-09-10 抗炎症活性を有する脂質抽出物

Country Status (12)

Country Link
US (2) US6083536A (enExample)
EP (1) EP0850068B1 (enExample)
JP (1) JP4101876B2 (enExample)
AT (1) ATE293984T1 (enExample)
AU (1) AUPN531195A0 (enExample)
CA (1) CA2231803C (enExample)
DE (1) DE69634666T2 (enExample)
DK (1) DK0850068T3 (enExample)
ES (1) ES2241001T3 (enExample)
PT (1) PT850068E (enExample)
WO (1) WO1997009992A1 (enExample)
ZA (1) ZA967626B (enExample)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPN531195A0 (en) * 1995-09-11 1995-10-05 J.W. Broadbent Nominees Pty. Ltd. Lipid extract having anti-inflamatory activity
JP2002502311A (ja) 1997-06-04 2002-01-22 セルラー インプルーブメンツ リミテッド 生物材料の破砕のための方法および装置
SE9703085D0 (sv) * 1997-08-27 1997-08-27 Micro Active Protein In Sweden Anti-microbial composition
US6946144B1 (en) 1998-07-08 2005-09-20 Oryxe Transdermal delivery system
US7220427B2 (en) 1998-07-08 2007-05-22 Oryxe Mixture for transdermal delivery of low and high molecular weight compounds
DE19838794A1 (de) * 1998-08-26 2000-03-09 Aristavet Veterinaerspezialita Zusammensetzung zur Behandlung von Osteoarthritis und zur nutritiven Behandlung des Gelenkknorpels
AUPP910699A0 (en) * 1999-03-10 1999-04-01 Pharmalink International Limited Inhibitor of lipoxygenase pathways
AU2005200953B2 (en) * 1999-03-22 2007-07-12 Mars, Incorporated Pet food for maintenance of joint health and alleviation of arthritic symptoms in companion animals and method of manufacturing same
US6596303B1 (en) * 1999-03-22 2003-07-22 Mars Incorporated Pet food for maintenance of joint health and alleviation of arthritic symptoms in companion animals
US20020018787A1 (en) * 1999-05-21 2002-02-14 Roger V. Kendall Methods and compositions for modulating immune response and for the treatment of inflammatory disease
DE60038320D1 (de) * 1999-07-21 2008-04-24 Bomac Research Ltd Mittel zur bekämpfung von entzündungen und/oder degenerativen erkrankungen
WO2001013956A2 (en) * 1999-08-26 2001-03-01 Ganeden Biotech, Inc. Use of emu oil a carrier for antifungal, antibacterial, and antiviral medications
AUPR030800A0 (en) * 2000-09-22 2000-10-12 Pharmalink International Limited Immunomodulatory preparation
AU9347701A (en) * 2000-09-22 2002-04-02 Pharmalink Internat Ltd Immunomodulatory preparation
US7519546B2 (en) * 2001-04-30 2009-04-14 General Electric Company Maintaining synchronization of information published to multiple subscribers
DK1417211T3 (da) 2001-07-27 2007-10-08 Neptune Technologies & Bioress Naturlige phospholipider af marin oprindelse, der indeholder flavonoider og polyumættede phospholipider, og deres anvendelse
AUPS082102A0 (en) * 2002-03-01 2002-03-21 Women's And Children's Hospital Therapeutic properties of oils
AU2003222002A1 (en) * 2002-03-14 2003-09-29 Jackie H. Mcclung Pharmaceutically active compounds containing phosphorous defficient oil
DE20210182U1 (de) * 2002-07-01 2002-10-02 Bio-Innovation Development Ltd., Christchurch Wirkstoffzusammensetzung aus Bestandteilen der Grünlippenmuschel (perna canaliculus) und zusätzlichen Omega-3-Fettsäuren
JP2006520389A (ja) * 2003-03-14 2006-09-07 フードサイエンス、コーポレイション Pernacanaliculus成分およびpernacanaliculusエキスを用いる癌の処置方法
US7052715B2 (en) * 2003-04-11 2006-05-30 All Natural Fmg, Inc. Alcohol-free transdermal analgesic composition and processes for manufacture and use thereof
US7033998B2 (en) * 2003-04-11 2006-04-25 All Natural Fmg, Inc. Alcohol-free transdermal insulin composition and processes for manufacture and use thereof
CA2554932A1 (en) * 2004-01-30 2005-08-11 Bionovate Limited Solvent extraction of lipids such as essential fatty acids
GB0411165D0 (en) * 2004-05-19 2004-06-23 Bionovate Ltd Hyaluronic acid containing pharmaceutical or veterinary compounds
GB0411166D0 (en) * 2004-05-19 2004-06-23 Bionovate Ltd Treatment for asthma and arthritis
US20060039992A1 (en) * 2004-06-02 2006-02-23 Miller Bruce A Jr Novel compositions and methods utilizing green-lipped mussel and fatty acids
WO2006052150A1 (en) * 2004-11-15 2006-05-18 University Of Otago Mussel extract composition with enhanced anti-inflammatory activity
US8092839B2 (en) * 2004-12-13 2012-01-10 Swing Aerobics Licensing, Inc. Medicament for treatment of cancer and other diseases
US8431165B2 (en) * 2004-12-13 2013-04-30 Swing Aerobics Licensing, Inc. Medicament for treatment of cancer and other diseases
NZ563125A (en) * 2005-06-03 2009-11-27 Mcfarlane Marketing Aust Pty L Lipid extract of mussels and method for preparation thereof
NZ547429A (en) * 2006-05-24 2009-09-25 Ind Res Ltd Extraction of highly unsaturated lipids with liquid dimethyl ether
US20090238763A1 (en) * 2006-07-09 2009-09-24 Chongxi Yu High penetration compositions and uses thereof
US20090221703A1 (en) 2006-07-09 2009-09-03 Chongxi Yu High penetration composition and uses thereof
HUE033687T2 (en) 2006-07-18 2017-12-28 Techfields Biochem Co Ltd Ibuprofen positively charged water soluble prodrugs with very fast skin penetration rates
PL2046727T3 (pl) 2006-07-25 2014-08-29 Techfields Biochem Co Ltd Dodatnio naładowane rozpuszczalne w wodzie proleki diklofenaku o bardzo szybkim stopniu przenikania przez skórę
PT2049482E (pt) 2006-08-08 2016-02-24 Techfields Biochem Co Ltd Profármacos solúveis em água carregados positivamente de ácidos aril- e heteroarilacéticos com velocidade de penetração na pele muito rápida
PL2084132T3 (pl) 2006-09-03 2019-03-29 Techfields Biochem Co. Ltd Dodatnio naładowane rozpuszczalne w wodzie proleki z kwasów n-arylantranilowych z bardzo szybką penetracją skóry
EP3388417A1 (en) 2006-09-03 2018-10-17 Techfields Biochem Co. Ltd Positively charged water-soluble prodrugs of acetaminophen and related compounds with very fast skin penetration rate
WO2008035756A1 (en) * 2006-09-22 2008-03-27 Heimat Co., Ltd. Anti-angiogenic composition comprising extract having anti-angiogenic activity and lecithin
CA2665081C (en) * 2006-10-02 2015-12-01 Techfields Biochem Co. Ltd Positively charged water-soluble prodrugs of prostaglandins and related compounds with very high skin penetration rates
EP2084165B1 (en) 2006-10-11 2013-06-12 Techfields Biochem Co. Ltd Positively charged water-soluble prodrugs of oxicams and related compounds with very high skin penetration rate
NZ552238A (en) * 2006-12-20 2009-07-31 Seperex Nutritionals Ltd An extract
WO2008146298A1 (en) * 2007-06-01 2008-12-04 Ganga Raju Gokaraju Use of aphanamixis polystacha extracts or fractions against 5 -lipoxygenase mediated diseases
JP2010529101A (ja) * 2007-06-04 2010-08-26 テックフィールズ インコーポレイテッド 非常に速い皮膚及び膜浸透速度を有するnsaiaプロドラッグ及びその新規医薬使用
AU2008355537B2 (en) * 2008-04-28 2014-02-06 21 Holding Sas Di Monico Cav. Silvano Pharmaceutical formulation containing palmitoyl ethanolamide and stearoyl ethanolamide
CN108191846B (zh) 2008-12-04 2021-08-20 于崇曦 高穿透性组合物及其应用
JP5313064B2 (ja) * 2009-07-03 2013-10-09 株式会社ノエビア 中性脂肪蓄積促進剤、豊胸剤
HK1207562A1 (en) 2012-01-18 2016-02-05 苏州泰飞尔医药有限公司 High penetration prodrug compositions and pharmaceutical composition thereof for treatment of pulmonary conditions
EP2938324B1 (en) 2012-12-31 2023-11-08 JRX Biotechnology, Inc. Liquid topical pharmaceutical nano-emulsion formulations
JP6176655B2 (ja) * 2013-07-02 2017-08-09 御木本製薬株式会社 マトリックスメタロプロテアーゼ活性阻害剤、皮膚外用剤、老化防止用皮膚外用剤、シワ防止用皮膚外用剤、慢性関節リウマチ及び他の疾患の治療又は予防剤
BR112018000953A2 (pt) * 2015-07-20 2018-09-11 Bengt I. Samuelsson Institute Of Life Science Research produto de proteína adesiva de mexilhão e aplicações do mesmo na supressão de inflamações de pele
EP3349717A4 (en) 2015-09-17 2019-04-17 JRX Biotechnology, Inc. APPROACHES TO IMPROVE SKIN HYDROGENATION OR HUMIDIFICATION
AU2017380470B2 (en) * 2016-12-20 2022-12-22 Sanford Limited Method of processing shellfish and resulting compositions
CN111432654A (zh) * 2017-12-04 2020-07-17 雾凇科技有限公司 从甲壳类捕获物中生产蛋白质磷脂复合物的方法
NZ755776A (en) * 2017-12-22 2020-05-29 Pharmalink International Ltd Lipid combinations
BR112022014320A2 (pt) * 2020-01-21 2022-09-13 Lintbells Ltd Composição, produto alimentar, nutracêutico ou suplemento e método para tratar um indivíduo
US12604918B2 (en) 2020-01-21 2026-04-21 Lintbells Limited Synergistic compositions
CN113041263B (zh) * 2021-03-15 2023-07-25 青岛大学 一种贻贝功能性脂质在制备治疗2型糖尿病产品中的应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0010061B1 (en) * 1978-09-25 1983-07-13 Stuart John Mc Farlane Pharmaceutical preparations containing a mollusc extract
US4801453A (en) 1984-05-01 1989-01-31 James M. Broadbent Stabilized mussel extract
AUPM740594A0 (en) 1994-08-11 1994-09-01 J.W. Broadbent Nominees Pty. Ltd. Anti-inflammatory preparation
AU3156595A (en) * 1994-08-11 1996-03-07 J.W. Broadbent Nominees Pty. Ltd. Anti-inflammatory preparation
AUPN531195A0 (en) * 1995-09-11 1995-10-05 J.W. Broadbent Nominees Pty. Ltd. Lipid extract having anti-inflamatory activity

Similar Documents

Publication Publication Date Title
JPH11509450A5 (enExample)
JP2000500228A5 (enExample)
JP2000500445A5 (enExample)
JP2000500440A5 (enExample)
JP2000500033A5 (enExample)
JP2002514946A5 (enExample)
JP2000500145A5 (enExample)
JP2000500155A5 (enExample)
JP2001518121A5 (enExample)
JP2001523979A5 (enExample)
JP2000500361A5 (enExample)
JP2000500115A5 (enExample)
JP2000500322A5 (enExample)
JP2000500258A5 (enExample)
JPH11513819A5 (enExample)
JP2000500342A5 (enExample)
JP2000500192A5 (enExample)
JP2000500112A5 (enExample)
JP2000500051A5 (enExample)
JP2000500166A5 (enExample)
JP2000500407A5 (enExample)
JP2000500397A5 (enExample)
JP2000500019A5 (enExample)
JP2000500125A5 (enExample)
JP2000500044A5 (enExample)